Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 21 hours ago“This is the start of a banner year for our vaccine platform as we continue to advance mRNA...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 10 hours agoModerna maintains its full-year 2024 guidance. The company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 day agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 7 hours agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days ago(NASDAQ:MRNA) have been quite disappointing recently and CEO Stephane Bancel bears some...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 1 day agoStrategic Developments and Future Outlook Moderna's CEO, Stephane Bancel, emphasized the company's...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 12 hours agoAnd help us understand, as you've communicated with large retail pharmacy, how significant the PFS formulation is to them? A: (Stephane Bancel -
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 1 day agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 1 day agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 day agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
